Researchers believe that CBD's ability to positively influence the functioning of the endocannabinoid system and other brain signaling systems could be a benefit and value for people with neurological disorders.
In fact, one of the most studied properties of CBD has been associated with treating neurological disorders such as epilepsy and multiple sclerosis. Although these studies are relatively new, many have shown promising positive results.
The spray, which is a combination of CBD and THC, has been tested and proven to be safe and effective for reducing spastic muscle contractions in patients suffering from multiple sclerosis.
In one study, the effectiveness of the preparation was 75%, with 276 people with multiple sclerosis tested, who experienced spastic muscle contractions resistant to traditional pharmacological treatment.
Another study gave 214 people with severe seizures between about 2 and about 5 grams of CBD oil per kg of body weight. The intensity of epileptic attacks decreased by an average of 36.5%.
Another study found that CBD oil significantly reduced epilepsy activity in children suffering from Dravet syndrome, a very complex childhood epileptic disorder, compared to the placebo group.
It is important to note that in both of these studies, some patients experienced the opposite effects of convulsions, fever or diarrhea.
CBD, such as CBD oil, has also been investigated for its potentially positive efficacy in treating several other neurological disorders.
For example, some studies have found that CBD improves quality of life and improves the sleep quality of Parkinson's patients.
Additionally, test-tube and animal studies have shown that CBD, by acting as an anti-inflammatory agent, can reduce inflammation and help prevent the neurodegenerative effects associated with Alzheimer's disease.
In one long-term study, scientists administered CBD to mice genetically predisposed to developing Alzheimer's disease, finding that CBD helps prevent cognitive decline.
SUMMARY:
Although the number of studies is still limited at present, CBD has been shown to be effective in treating symptoms related to epilepsy and Parkinson's disease. CBD has also been shown to be effective in inhibiting the development of Alzheimer's disease in test-tube and laboratory animal studies.